Level A· Stronger Clinical EvidenceMeta-analysisEurope PMC

Functional and Return-to-Sport Outcomes After Biologic Augmentation in Anterior Cruciate Ligament Reconstruction: A Systematic Review and Meta-analysis

Alturki AA., Alanazi AS., Alshehri AF., Benmeakel MA., Alenazi FS., Aljuhani TA.

Meta-analysis on Ligament Injury, published in Orthop Rev (Pavia) (2026) — summary generated from the PubMed abstract.

Open my reading list
Level A· Stronger Clinical EvidenceEvidence level of this study

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Meta-analysis
Journal
Orthop Rev (Pavia) (2026)
Reported sample size
—
Source database
Europe PMC
PMID
42282137
PMCID
PMC13252956
DOI
10.52965/001c.162663

Abstract (original English)

Background The clinical value of biologic augmentation during anterior cruciate ligament reconstruction remains uncertain, particularly regarding functional recovery and return to sport. Existing evidence has yielded inconsistent results, and prior syntheses have often emphasized radiologic outcomes rather than patient-centered functional measures. Methods A systematic review and random-effects meta-analysis of comparative clinical studies evaluating biologic augmentation during anterior cruciate ligament reconstruction was conducted. PubMed, the Cochrane Library, and Google Scholar were searched without date restrictions. Tegner activity score, Lysholm knee score, International Knee Documentation Committee score, and return-to-sport outcomes were analyzed when available. Risk of bias was assessed using the Cochrane Risk of Bias 2 tool and the MINORS criteria. Results Ten studies were included. Biologic augmentation was associated with higher Tegner activity scores compared with standard reconstruction, with a pooled mean difference of 0.52 (95% confidence interval 0.14 to 0.91) and no observed heterogeneity. Lysholm knee scores were also higher in the biologic augmentation group (mean difference 3.32, 95% confidence interval 0.65 to 6.00), although substantial heterogeneity persisted across studies. No significant difference was observed in pooled International Knee Documentat

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research